ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

ClinicalTrials.gov ID: NCT03624127

Public ClinicalTrials.gov record NCT03624127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis

Study identification

NCT ID
NCT03624127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
666 participants

Conditions and interventions

Conditions

Interventions

  • Apremilast Drug
  • BMS-986165 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 6, 2018
Primary completion
Sep 1, 2020
Completion
Sep 1, 2020
Last update posted
Jan 29, 2023

2018 – 2020

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
60
Facility City State ZIP Site status
Achieve Clinical Research Birmingham Alabama 35216
Coastal Clinical Research - Mobile Mobile Alabama 36608
Elite Clinical Studies Phoenix Arizona 85018
Arizona Research Center Phoenix Arizona 85053
Synexus - Tucson Tucson Arizona 85741
Hull Dermatology Rogers Arkansas 72758
First OC Dermatology & Belle-Aimee Skincare Clinic Fountain Valley Fountain Valley California 92708
University California at Irvine Dermatology Clinical Research Center Irvine California 92697
Keck School of Medicine Los Angeles California 90033
Dream Team Clinical Research Pomona California 91767
University Dermatology Group San Diego California 92123
Unison Clinical Trials Sherman Oaks California 91403
New England Research Associates Bridgeport Connecticut 06606
Precision Clinical Research Davie Florida 33328
Indago Research and Health Center Hialeah Florida 33012
LCC Medical Research Miami Florida 33126
International Dermatology Research Miami Florida 33144
Well Pharma Medical Research Miami Florida 33173
Miami Dade Medical Research Institute Miami Florida 33176
San Marcus Research Clinic Miami Lakes Florida 33014
Renstar Medical Research Ocala Florida 34471
Ameriderm Research Ormond Beach Florida 32174
Olympian Clinical Research Tampa Florida 33614-7118
Palm Beach Research Center West Palm Beach Florida 33409-3401
Hamilton Dermatology Alpharetta Georgia 30022
Healthcare Research Network - Flossmoor Flossmoor Illinois 60402
Springfield Clinic Springfield Illinois 62703
Deaconess Clinic Downtown Evansville Indiana 47708
The Dermatology Center New Albany Indiana 47150
The Indiana Clinical Trials Center Plainfield Indiana 46168
The South Bend Clinic South Bend Indiana 46617
Kansas City Dermatology Overland Park Kansas 66215
Dermatology Specialists Research-Kentucky Louisville Kentucky 40241
Clinical Trials of America - Monroe Monroe Louisiana 71201
Etre Cosmetic Dermatology and Laser Center New Orleans Louisiana 70130
ActivMed Practices and Research - Beverly Beverly Massachusetts 01915
DermCare Experts Quincy Massachusetts 02169
David Fivenson MD Dermatology Ann Arbor Michigan 48103
Somerset Skin Centre Troy Michigan 48084
Associated Skin Care Specialists - Minnesota Clinical Study Center New Brighton Minnesota 55112
MediSearch Clinical Trials Saint Joseph Missouri 64506
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Hassman Research Institute Berlin New Jersey 08009
Forest Hills Dermatology Group Kew Gardens New York 11374
Mount Sinai - Queens New York New York 10023
PMG Research of Charlotte Charlotte North Carolina 28209
Duke University Health System - Duke Clinic Durham North Carolina 27710-4000
M3 Wake Research, Inc. Raleigh North Carolina 27612
The Ohio State University Wexner Medical Center Columbus Ohio 43203
Synexus - Columbus Columbus Ohio 43212
Health Research of Oklahoma Oklahoma City Oklahoma 73103-2433
Oregon Medical Research Center Portland Oregon 97223-6683
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Clinical Research Center of Reading Wyomissing Pennsylvania 19610
Synexus Clinical Research - Anderson Anderson South Carolina 29621
Clinical Research Center of the Carolinas Charleston South Carolina 29407
Interspond - Stones River Dermatology - Murfreesboro Office Murfreesboro Tennessee 37129
Westlake Dermatology - Westlake Austin Texas 78746
Dermatology Treatment and Research Center Dallas Texas 75230
Metroplex Clinical Research Center Dallas Texas 75231
Menter Dermatology Research Institute Dallas Texas 75246
Austin Institute for Clinical Research - Pflugerville Pflugerville Texas 78660
University of Texas Health Science Center at San Antonio San Antonio Texas 78218
Interspond - Acclaim Dermatology Sugar Land Texas 77479
Center for Clinical Studies - Webster Webster Texas 77598
Dermatology Associates of Seattle Seattle Washington 98101
Eastern Washington Dermatology Walla Walla Washington 99362

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03624127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2023 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03624127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →